Get the Stockscreener App
0.0178
2.73%
-0.0005
Nls Pharmaceutics Ag stock is traded at $0.0178, with a volume of 24,214.
It is down -2.73% in the last 24 hours and up +25.35% over the past month.
NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company also developing NLS-4, a selective dopamine reuptake inhibitor to prevent rare sleep disorders; NLS-3, a repurposed reverse ester of methylphenidate for treatment of ADHD; NLS-8, a melatonin ML1A receptor agonist, improved scopolamine-induced amnesia; NLS-11, a norepinephrine and dopamine reuptake inhibitor and muscarinic M1, M2, M3 receptor antagonist; and NLS-12, a norepinephrine and dopamine reuptake inhibitor and muscarinic M4 receptor antagonist. NLS Pharmaceutics AG was incorporated in 2015 and is based in Zurich, Switzerland.
See More
Previous Close:
$0.0183
Open:
$0.0198
24h Volume:
24,214
Relative Volume:
0.56
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+7.23%
1M Performance:
+25.35%
6M Performance:
+15.58%
1Y Performance:
-5.32%
1-Day Range:
$0.0177
$0.0198
1-Week Range:
$0.0161
$0.02
52-Week Range:
$0.0009
$0.0698
Nls Pharmaceutics Ag Stock (NLSPW) Company Profile
Name
Nls Pharmaceutics Ag
Sector
Industry
Phone
41 44 512 21 50
Address
The Circle 6, Zurich
Compare NLSPW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NLSPW
Nls Pharmaceutics Ag
|
0.0178 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Nls Pharmaceutics Ag Stock (NLSPW) Latest News
Will NLS Pharmaceutics AG Equity Warrant benefit from macro trends2025 Technical Overview & High Accuracy Trade Alerts - Newser
Published on: 2025-08-20 15:01:54 - Newser
Can NLS Pharmaceutics AG recover in the next quarterTrade Risk Report & Free Expert Approved Momentum Trade Ideas - Newser
Will earnings trigger a reversal in NLS Pharmaceutics AG2025 AllTime Highs & Verified Short-Term Plans - Newser
Does NLS Pharmaceutics AG Equity Warrant qualify in momentum factor screeningQuarterly Profit Review & Risk Adjusted Buy and Sell Alerts - Newser
Risk vs reward if holding onto NLS Pharmaceutics AGTrade Exit Summary & Weekly High Return Forecasts - Newser
NLS Pharmaceutics AG stock chart pattern explainedMarket Performance Report & Precise Buy Zone Tips - Newser
Measuring NLS Pharmaceutics AG Equity Warrant’s beta against major indicesJuly 2025 Retail & Weekly High Return Stock Opportunities - Newser
Tools to assess NLS Pharmaceutics AG’s risk profileJuly 2025 Drop Watch & Intraday High Probability Alerts - Newser
Tools to monitor NLS Pharmaceutics AG recovery probabilityEntry Point & High Return Trade Guides - Newser
Is this a good reentry point in NLS Pharmaceutics AG Equity WarrantQuarterly Profit Review & Long-Term Capital Growth Strategies - Newser
Understanding NLS Pharmaceutics AG’s price movementJuly 2025 Retail & AI Forecasted Entry and Exit Points - Newser
Regression analysis insights on NLS Pharmaceutics AG performanceRisk Management & Daily Entry Point Alerts - Newser
Published on: 2025-08-19 14:52:04 - Newser
Using Bollinger Bands to evaluate NLS Pharmaceutics AGPortfolio Return Summary & Real-Time Buy Signal Notifications - Newser
Chart overlay techniques for tracking NLS Pharmaceutics AGPortfolio Gains Summary & Technical Confirmation Trade Alerts - Newser
Does NLS Pharmaceutics AG fit your quant trading modelWeekly Trade Analysis & Risk Controlled Swing Alerts - Newser
Volume spikes in NLS Pharmaceutics AG stock – what they meanJuly 2025 Sentiment & AI Driven Stock Price Forecasts - Newser
Developing predictive dashboards with NLS Pharmaceutics AG Equity Warrant dataWeekly Profit Analysis & Free Expert Approved Momentum Trade Ideas - Newser
Published on: 2025-08-19 06:44:01 - 선데이타임즈
Is NLS Pharmaceutics AG part of any ETF2025 Dividend Review & Weekly Top Gainers Trade List - 선데이타임즈
How to escape a deep drawdown in NLS Pharmaceutics AG Equity WarrantTrade Risk Assessment & Expert Curated Trade Setups - Newser
Risk vs reward if holding onto NLS Pharmaceutics AG Equity Warrant2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - Newser
Chart based exit strategy for NLS Pharmaceutics AG Equity WarrantRisk Management & Daily Profit Focused Screening - Newser
Analyzing NLS Pharmaceutics AG with multi timeframe charts2025 Price Momentum & Weekly High Return Forecasts - Newser
Is NLS Pharmaceutics AG Equity Warrant a candidate for recovery play2025 Year in Review & Verified Chart Pattern Signals - Newser
Analyzing net buyer seller activity in NLS Pharmaceutics AG Equity WarrantJuly 2025 Fed Impact & Smart Money Movement Tracker - Newser
Custom watchlist performance reports with NLS Pharmaceutics AGMarket Trend Report & Verified High Yield Trade Plans - Newser
Candlestick signals on NLS Pharmaceutics AG stock todayJuly 2025 Short Interest & Accurate Buy Signal Alerts - Newser
Can trapped investors hope for a rebound in NLS Pharmaceutics AGJuly 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - Newser
NLS Pharmaceutics AG Equity Warrant Rebound Backed by Sentiment ShiftMarket Activity Recap & Precise Trade Entry Recommendations - metal.it
What Technical Tools Say About NLS Pharmaceutics AG Recovery - thegnnews.com
How to escape a deep drawdown in NLS Pharmaceutics AGPortfolio Growth Summary & Consistent Return Investment Signals - Newser
Advanced analytics toolkit walkthrough for NLS Pharmaceutics AGJuly 2025 Setups & AI Forecast Swing Trade Picks - Newser
Can momentum traders help lift NLS Pharmaceutics AG Equity WarrantJuly 2025 Retail & Consistent Profit Trade Alerts - Newser
Heatmap analysis for NLS Pharmaceutics AG and competitorsPortfolio Performance Summary & Stepwise Swing Trade Plans - Newser
What Fibonacci levels say about NLS Pharmaceutics AG reboundPortfolio Value Summary & Consistent Profit Trading Strategies - Newser
Why is NLS Pharmaceutics AG stock going down2025 Market WrapUp & Expert Curated Trade Setup Alerts - sundaytimes.kr
Using data models to predict NLS Pharmaceutics AG stock movementWeekly Trade Recap & Safe Capital Preservation Plans - Newser
Nls Pharmaceutics Ag Stock (NLSPW) Financials Data
There is no financial data for Nls Pharmaceutics Ag (NLSPW). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Cap:
|
Volume (24h):